COLC-Pro: COVID-19, Obesity and Lifestyle in Children - Role of Professionals

Sponsor
Maastricht University Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT05336591
Collaborator
(none)
385
1
12
32.2

Study Details

Study Description

Brief Summary

In this study it is researched how preventive and curative healthcare for children with overweight and obesity was conducted during the Covid-19 pandemic, which barriers were noticed by professionals, and how new methods (such as e-health and telemonitorning) for coaching, communication and healthcare were used and experienced.

Condition or Disease Intervention/Treatment Phase
  • Other: Covid-19 pandemic

Study Design

Study Type:
Observational
Anticipated Enrollment :
385 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
COVID-19, Obesity and Lifestyle in Children - Role of Professionals
Actual Study Start Date :
Apr 21, 2022
Anticipated Primary Completion Date :
Aug 1, 2022
Anticipated Study Completion Date :
Apr 20, 2023

Arms and Interventions

Arm Intervention/Treatment
Medical doctor

Other: Covid-19 pandemic
All participants worked during the Covid-19 pandemic in the preventive or curative healthcare for children with overweight and obesity. We will ask all professionals about their experiences during and after the pandemic.

Nurses (Pediatric department and youth healthcare)

Other: Covid-19 pandemic
All participants worked during the Covid-19 pandemic in the preventive or curative healthcare for children with overweight and obesity. We will ask all professionals about their experiences during and after the pandemic.

Other professionals in treatment (e.g. dieticians, physiotherapists)

Other: Covid-19 pandemic
All participants worked during the Covid-19 pandemic in the preventive or curative healthcare for children with overweight and obesity. We will ask all professionals about their experiences during and after the pandemic.

Other (such as policy makers)

Other: Covid-19 pandemic
All participants worked during the Covid-19 pandemic in the preventive or curative healthcare for children with overweight and obesity. We will ask all professionals about their experiences during and after the pandemic.

Outcome Measures

Primary Outcome Measures

  1. Views and experiences of health care professionals working with children with overweight and obesity during the COVID-19 pandemic [2 years after the start of the Covid-19 pandemic]

    Views and experiences of health care professionals working with children with overweight and obesity during the COVID-19 pandemic measured with a questionnaire using open-end and closed-end (likert-scale) questions.

  2. User experience [2 years after the start of the Covid-19 pandemic]

    User experience of professionals using ehealth options in healthcare for children with overweight or obesity, measured with a questionnaire using closed end and open end questions.

Secondary Outcome Measures

  1. Experiences [2 years after the start of the Covid-19 pandemic]

    In case more in-depth data is needed after the inital questionnaire, semi-structured interviews will be conducted to experiences of health care professionals during the Covid-19 pandemic.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Worked during the Covid-19 pandemic

  • Works with children with overweight and / or obesity

  • Works in The Netherlands

Exclusion Criteria:
  • No knowledge of the Dutch language.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Maastricht University Medical Center Maastricht Limburg Netherlands 6229 ER

Sponsors and Collaborators

  • Maastricht University Medical Center

Investigators

  • Principal Investigator: Anita CE Vreugdenhil, Prof, MUMC+, Maastricht University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Maastricht University Medical Center
ClinicalTrials.gov Identifier:
NCT05336591
Other Study ID Numbers:
  • 2020-1634
First Posted:
Apr 20, 2022
Last Update Posted:
Aug 12, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 12, 2022